Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study

INTRODUCTION: Individualised treatment through therapeutic drug monitoring (TDM) may improve tuberculosis (TB) treatment outcomes but is not routinely implemented. Prospective clinical studies of drug exposure and minimum inhibitory concentrations (MICs) in multidrug-resistant TB (MDR-TB) are scarce...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies Forsman, Lina, Niward, Katarina, Hu, Yi, Zheng, Rongrong, Zheng, Xubin, Ke, Ran, Cai, Weiping, Hong, Chao, Li, Yang, Gao, Yazhou, Werngren, Jim, Paues, Jakob, Kuhlin, Johanna, Simonsson, Ulrika S H, Eliasson, Erik, Alffenaar, Jan-Willem, Mansjö, Mikael, Hoffner, Sven, Xu, Biao, Schön, Thomas, Bruchfeld, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173237/
https://www.ncbi.nlm.nih.gov/pubmed/30287613
http://dx.doi.org/10.1136/bmjopen-2018-023899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173237/
https://www.ncbi.nlm.nih.gov/pubmed/30287613
http://dx.doi.org/10.1136/bmjopen-2018-023899

Ejemplares similares